1	Pathogenesis	Pathogenesis	B-NP	NN	O	9	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	the	the	B-NP	DT	O	4	NMOD
4	hyperlipidemia	hyperlipidemia	I-NP	NN	O	2	PMOD
5	of	of	B-PP	IN	O	4	NMOD
6	Gram-negative	Gram-negative	B-NP	JJ	O	7	AMOD
7	bacterial	bacterial	I-NP	JJ	O	8	NMOD
8	sepsis	sepsis	I-NP	NN	O	5	PMOD
9	may	may	B-VP	MD	O	0	ROOT
10	involve	involve	I-VP	VB	O	9	VC
11	pathomorphological	pathomorphological	B-NP	JJ	O	12	NMOD
12	changes	change	I-NP	NNS	O	10	OBJ
13	in	in	B-PP	IN	O	12	NMOD
14	liver	liver	B-NP	NN	B-cell_type	17	NMOD
15	sinusoidal	sinusoidal	I-NP	JJ	I-cell_type	17	NMOD
16	endothelial	endothelial	I-NP	JJ	I-cell_type	17	NMOD
17	cells	cell	I-NP	NNS	I-cell_type	13	PMOD
18	.	.	O	.	O	9	P

1	The	The	B-NP	DT	O	5	NMOD
2	Gram-negative	Gram-negative	I-NP	JJ	O	5	NMOD
3	bacterium	bacterium	I-NP	NN	O	5	NMOD
4	Pseudomonas	Pseudomonas	I-NP	NN	O	5	NMOD
5	aeruginosa	aeruginosa	I-NP	NN	O	6	SUB
6	is	be	B-VP	VBZ	O	0	ROOT
7	one	one	B-NP	CD	O	6	PRD
8	of	of	B-PP	IN	O	7	NMOD
9	the	the	B-NP	DT	O	13	NMOD
10	most	most	I-NP	RBS	O	11	AMOD
11	common	common	I-NP	JJ	O	13	NMOD
12	opportunistic	opportunistic	I-NP	JJ	O	13	NMOD
13	pathogens	pathogen	I-NP	NNS	O	8	PMOD
14	,	,	O	,	O	6	P
15	especially	especially	B-ADVP	RB	O	16	PMOD
16	after	after	B-PP	IN	O	6	VMOD
17	liver	liver	B-NP	NN	O	18	NMOD
18	transplantation	transplantation	I-NP	NN	O	16	PMOD
19	.	.	O	.	O	6	P

1	Pathophysiological	Pathophysiological	B-NP	JJ	O	2	NMOD
2	alterations	alteration	I-NP	NNS	O	11	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	liver	liver	B-NP	NN	B-cell_type	7	NMOD
5	sinusoidal	sinusoidal	I-NP	JJ	I-cell_type	7	NMOD
6	endothelial	endothelial	I-NP	JJ	I-cell_type	7	NMOD
7	cells	cell	I-NP	NNS	I-cell_type	3	PMOD
8	(	(	O	(	O	10	DEP
9	LSECs	LSEC	B-NP	NNS	B-cell_type	10	DEP
10	)	)	O	)	O	7	NMOD
11	have	have	B-VP	VBP	O	0	ROOT
12	far-reaching	far-reaching	B-NP	JJ	O	13	NMOD
13	repercussions	repercussion	I-NP	NNS	O	11	OBJ
14	on	on	B-PP	IN	O	11	VMOD
15	the	the	B-NP	DT	O	16	NMOD
16	liver	liver	I-NP	NN	O	14	PMOD
17	and	and	B-PP	CC	O	14	PMOD
18	on	on	B-PP	IN	O	14	PMOD
19	metabolism	metabolism	B-NP	NN	O	18	PMOD
20	.	.	O	.	O	11	P

1	LSECs	LSEC	B-NP	NNS	B-cell_type	2	SUB
2	are	be	B-VP	VBP	O	0	ROOT
3	perforated	perforate	I-VP	VBN	O	2	VC
4	with	with	B-PP	IN	O	3	VMOD
5	fenestrations	fenestration	B-NP	NNS	O	7	NMOD
6	,	,	O	,	O	7	P
7	pores	pore	B-NP	NNS	O	4	PMOD
8	that	that	B-NP	WDT	O	7	NMOD
9	facilitate	facilitate	B-VP	VBP	O	8	SBAR
10	the	the	B-NP	DT	O	11	NMOD
11	transfer	transfer	I-NP	NN	O	9	OBJ
12	of	of	B-PP	IN	O	11	NMOD
13	lipoproteins	lipoprotein	B-NP	NNS	B-protein	15	NMOD
14	and	and	I-NP	CC	O	15	NMOD
15	macromolecules	macromolecule	I-NP	NNS	O	12	PMOD
16	between	between	B-PP	IN	O	15	NMOD
17	blood	blood	B-NP	NN	O	19	NMOD
18	and	and	I-NP	CC	O	19	NMOD
19	hepatocytes	hepatocyte	I-NP	NNS	B-cell_type	16	PMOD
20	.	.	O	.	O	2	P

1	Gram-negative	Gram-negative	B-NP	JJ	B-protein	3	NMOD
2	bacterial	bacterial	I-NP	JJ	I-protein	3	NMOD
3	endotoxin	endotoxin	I-NP	NN	I-protein	15	NMOD
4	(	(	O	(	O	8	DEP
5	lipopolysaccharide	lipopolysaccharide	B-NP	NN	O	7	NMOD
6	,	,	O	,	O	7	P
7	LPS	LPS	B-NP	NN	O	8	DEP
8	)	)	O	)	O	3	NMOD
9	and	and	O	CC	O	15	NMOD
10	the	the	B-NP	DT	O	13	NMOD
11	P.	P.	I-NP	NNP	O	13	NMOD
12	aeruginosa	aeruginosa	I-NP	NN	O	13	NMOD
13	toxin	toxin	I-NP	NN	O	15	NMOD
14	,	,	O	,	O	15	P
15	pyocyanin	pyocyanin	B-NP	NN	O	17	SUB
16	,	,	O	,	O	15	P
17	have	have	B-VP	VBP	O	0	ROOT
18	marked	mark	I-VP	VBN	O	17	VC
19	effects	effect	B-NP	NNS	O	18	OBJ
20	on	on	B-PP	IN	O	19	NMOD
21	LSECs	LSEC	B-NP	NNS	B-cell_type	20	PMOD
22	.	.	O	.	O	17	P

1	Initial	Initial	B-NP	JJ	O	2	NMOD
2	loss	loss	I-NP	NN	O	16	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	LSEC	LSEC	B-NP	NNP	O	5	NMOD
5	porosity	porosity	I-NP	NN	O	3	PMOD
6	(	(	O	(	O	8	DEP
7	defenestration	defenestration	B-NP	NN	O	8	DEP
8	)	)	O	)	O	5	NMOD
9	induced	induce	B-VP	VBN	O	5	NMOD
10	by	by	B-PP	IN	O	9	VMOD
11	P.	P.	B-NP	NNP	O	12	NMOD
12	aeruginosa	aeruginosa	I-NP	NNP	O	15	NMOD
13	pyocyanin	pyocyanin	I-NP	NN	O	12	NMOD
14	and	and	I-NP	CC	O	12	NMOD
15	LPS	LPS	I-NP	NN	O	10	PMOD
16	may	may	B-VP	MD	O	0	ROOT
17	confer	confer	I-VP	VB	O	16	VC
18	subsequent	subsequent	B-NP	JJ	O	20	NMOD
19	immune	immune	I-NP	JJ	O	20	NMOD
20	tolerance	tolerance	I-NP	NN	O	17	OBJ
21	to	to	B-PP	TO	O	17	VMOD
22	circulating	circulate	B-VP	VBG	O	26	NMOD
23	bacterial	bacterial	B-NP	JJ	B-protein	24	NMOD
24	antigens	antigen	I-NP	NNS	I-protein	26	NMOD
25	and	and	I-NP	CC	O	26	NMOD
26	toxins	toxin	I-NP	NNS	O	21	PMOD
27	.	.	O	.	O	16	P

1	This	This	B-NP	DT	O	2	NMOD
2	review	review	I-NP	NN	O	3	SUB
3	collates	collate	B-VP	VBZ	O	0	ROOT
4	the	the	B-NP	DT	O	7	NMOD
5	known	known	I-NP	JJ	O	7	NMOD
6	immune	immune	I-NP	JJ	O	7	NMOD
7	responses	response	I-NP	NNS	O	3	OBJ
8	of	of	B-PP	IN	O	7	NMOD
9	the	the	B-NP	DT	O	10	NMOD
10	liver	liver	I-NP	NN	O	8	PMOD
11	to	to	B-PP	TO	O	3	VMOD
12	Gram-negative	Gram-negative	B-NP	JJ	O	14	NMOD
13	bacterial	bacterial	I-NP	JJ	O	14	NMOD
14	toxins	toxin	I-NP	NNS	O	11	PMOD
15	,	,	O	,	O	3	P
16	with	with	B-PP	IN	O	3	VMOD
17	a	a	B-NP	DT	O	18	NMOD
18	focus	focus	I-NP	NN	O	16	PMOD
19	on	on	B-PP	IN	O	18	NMOD
20	LSECs	LSEC	B-NP	NNS	B-cell_type	19	PMOD
21	.	.	O	.	O	3	P

1	Hyperlipidemia	Hyperlipidemia	B-NP	NN	O	2	SUB
2	is	be	B-VP	VBZ	O	0	ROOT
3	an	an	B-NP	DT	O	5	NMOD
4	important	important	I-NP	JJ	O	5	NMOD
5	response	response	I-NP	NN	O	2	PRD
6	to	to	B-PP	TO	O	5	NMOD
7	Gram-negative	Gram-negative	B-NP	JJ	O	8	AMOD
8	bacterial	bacterial	I-NP	JJ	O	9	NMOD
9	sepsis	sepsis	I-NP	NN	O	6	PMOD
10	.	.	O	.	O	2	P

1	The	The	B-NP	DT	O	2	NMOD
2	mechanisms	mechanism	I-NP	NNS	O	7	SUB
3	proposed	propose	B-VP	VBN	O	2	NMOD
4	for	for	B-PP	IN	O	3	VMOD
5	sepsis-associated	sepsis-associated	B-NP	JJ	O	6	NMOD
6	hyperlipidemia	hyperlipidemia	I-NP	NN	O	4	PMOD
7	include	include	B-VP	VBP	O	0	ROOT
8	tissue	tissue	B-NP	NN	B-protein	10	NMOD
9	lipoprotein	lipoprotein	I-NP	NN	I-protein	10	NMOD
10	lipase	lipase	I-NP	NN	I-protein	11	NMOD
11	inhibition	inhibition	I-NP	NN	O	16	NMOD
12	and	and	O	CC	O	16	NMOD
13	upregulated	upregulate	B-VP	VBD	O	16	NMOD
14	hepatic	hepatic	B-NP	JJ	O	16	NMOD
15	triglyceride	triglyceride	I-NP	NN	O	16	NMOD
16	production	production	I-NP	NN	O	7	OBJ
17	.	.	O	.	O	7	P

1	In	In	B-PP	IN	O	6	VMOD
2	this	this	B-NP	DT	O	3	NMOD
3	review	review	I-NP	NN	O	1	PMOD
4	,	,	O	,	O	6	P
5	we	we	B-NP	PRP	O	6	SUB
6	propose	propose	B-VP	VBP	O	0	ROOT
7	defenestration	defenestration	B-NP	NN	O	6	OBJ
8	of	of	B-PP	IN	O	7	NMOD
9	the	the	B-NP	DT	O	10	NMOD
10	LSECs	LSEC	I-NP	NNS	B-cell_type	8	PMOD
11	by	by	B-PP	IN	O	7	NMOD
12	bacterial	bacterial	B-NP	JJ	B-protein	13	NMOD
13	toxins	toxin	I-NP	NNS	I-protein	11	PMOD
14	as	as	B-PP	IN	O	7	NMOD
15	an	an	B-NP	DT	O	17	NMOD
16	additional	additional	I-NP	JJ	O	17	NMOD
17	mechanism	mechanism	I-NP	NN	O	14	PMOD
18	for	for	B-PP	IN	O	17	NMOD
19	the	the	B-NP	DT	O	20	NMOD
20	hyperlipidemia	hyperlipidemia	I-NP	NN	O	18	PMOD
21	of	of	B-PP	IN	O	20	NMOD
22	sepsis	sepsis	B-NP	NN	O	21	PMOD
23	.	.	O	.	O	6	P

1	Given	Give	B-PP	VBN	O	24	VMOD
2	the	the	B-NP	DT	O	3	NMOD
3	role	role	I-NP	NN	O	1	PMOD
4	of	of	B-PP	IN	O	3	NMOD
5	LSECs	LSEC	B-NP	NNS	B-cell_type	4	PMOD
6	in	in	B-PP	IN	O	3	NMOD
7	hyperlipidemia	hyperlipidemia	B-NP	NN	O	11	NMOD
8	and	and	O	CC	O	11	NMOD
9	liver	liver	B-NP	NN	O	11	NMOD
10	allograft	allograft	I-NP	NN	O	11	NMOD
11	rejection	rejection	I-NP	NN	O	6	PMOD
12	,	,	O	,	O	24	P
13	LSEC	LSEC	B-NP	NNP	O	14	NMOD
14	changes	change	I-NP	NNS	O	24	SUB
15	induced	induce	B-VP	VBN	O	14	NMOD
16	by	by	B-PP	IN	O	15	VMOD
17	P.	P.	B-NP	NNP	B-protein	19	NMOD
18	aeruginosa	aeruginosa	I-NP	NNP	I-protein	19	NMOD
19	toxins	toxin	I-NP	NNS	I-protein	16	PMOD
20	including	include	B-PP	VBG	O	19	NMOD
21	LPS	LPS	B-NP	NN	O	23	NMOD
22	and	and	I-NP	CC	O	23	NMOD
23	pyocyanin	pyocyanin	I-NP	NN	O	20	PMOD
24	may	may	B-VP	MD	O	0	ROOT
25	have	have	I-VP	VB	O	24	VC
26	significant	significant	B-NP	JJ	O	27	AMOD
27	clinical	clinical	I-NP	JJ	O	28	NMOD
28	implications	implication	I-NP	NNS	O	25	OBJ
29	.	.	O	.	O	24	P

